Investors sold shares of Medtronic Inc. (NYSE:MDT) on strength during trading hours on Monday. $52.81 million flowed into the stock on the tick-up and $112.31 million flowed out of the stock on the tick-down, for a money net flow of $59.50 million out of the stock. Of all stocks tracked, Medtronic had the 0th highest net out-flow for the day. Medtronic traded up $0.43 for the day and closed at $88.06

A number of brokerages have commented on MDT. Bank of America Corp. restated a “buy” rating and set a $90.00 price objective on shares of Medtronic in a research report on Thursday, April 7th. Jefferies Group restated a “buy” rating on shares of Medtronic in a research report on Wednesday, June 1st. BTIG Research downgraded shares of Medtronic from a “buy” rating to a “neutral” rating and set a $82.00 price objective for the company. in a research report on Wednesday, June 1st. Credit Suisse Group AG restated a “buy” rating and set a $85.00 price objective on shares of Medtronic in a research report on Tuesday, May 31st. Finally, Royal Bank Of Canada restated a “buy” rating on shares of Medtronic in a research report on Wednesday, June 1st. Seven equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $87.88.

The firm has a market cap of $122.82 billion and a PE ratio of 35.51. The firm’s 50-day moving average price is $86.63 and its 200 day moving average price is $79.87.

Medtronic (NYSE:MDT) last issued its quarterly earnings results on Tuesday, May 31st. The medical technology company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.26 by $0.01. During the same quarter last year, the firm posted $1.16 earnings per share. The business earned $7.57 billion during the quarter, compared to the consensus estimate of $7.49 billion. Medtronic’s revenue was up 3.6% compared to the same quarter last year. Equities analysts predict that Medtronic Inc. will post $4.66 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 27th. Shareholders of record on Friday, July 8th were given a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.95%. The ex-dividend date was Wednesday, July 6th. This is an increase from Medtronic’s previous quarterly dividend of $0.38.

In other Medtronic news, EVP Bryan C. Hanson sold 15,000 shares of the business’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $87.00, for a total transaction of $1,305,000.00. Following the sale, the executive vice president now owns 108,717 shares in the company, valued at approximately $9,458,379. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Richard Kuntz sold 49,905 shares of the business’s stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $82.60, for a total value of $4,122,153.00. Following the sale, the vice president now owns 127,647 shares in the company, valued at approximately $10,543,642.20. The disclosure for this sale can be found here.

A number of hedge funds recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Medtronic by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 89,739,674 shares of the medical technology company’s stock valued at $6,902,776,000 after buying an additional 2,935,600 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. increased its stake in Medtronic by 2.8% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 191,907 shares of the medical technology company’s stock valued at $14,761,000 after buying an additional 5,257 shares during the last quarter. Howland Capital Management LLC increased its stake in Medtronic by 4.2% in the fourth quarter. Howland Capital Management LLC now owns 176,481 shares of the medical technology company’s stock valued at $13,575,000 after buying an additional 7,110 shares during the last quarter. SVA Plumb Wealth Management LLC increased its stake in Medtronic by 0.5% in the fourth quarter. SVA Plumb Wealth Management LLC now owns 44,808 shares of the medical technology company’s stock valued at $3,447,000 after buying an additional 235 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in Medtronic by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,841,019 shares of the medical technology company’s stock valued at $141,611,000 after buying an additional 27,459 shares during the last quarter.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.